Comments
Loading...
Viveve Medical Stock Guidance | OTC:VIVE | Benzinga
Viveve Medical issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/18/2021 | VIVE | Viveve Medical | Q4 | 2020 | — | — | — | $1.90M | $1.90M | $1.65M | Get Alert |
FAQ
What is the most recent guidance for Viveve Medical (VIVE)?
There have been no specific sales or earnings guidance reported for Viveve Medical in recent months.
Browse guidance and forecast on all stocks.
